Director · Century Therapeutics, Inc. · Century Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
88.0K
Price
—
Executed
Dec 9, 2025
Disclosed
Apr 10, 2026
Disclosure timeline122 days from execution to publication · legal deadline 2 business days
Dec 9 executedApr 10, 2026 disclosed
IPSC · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+15 / 15
Disclosed 88 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Century Therapeutics, Inc. — Stock Option (right to buy)
Ticker
IPSC
Shares
88.0K
Price per share
$0
Execution date (reported)
Dec 9, 2025
Owned after transaction
88.0K shares
Days from execution to publication
122
What this establishes
Murphy Martin Patrick filed this Form 4 reporting a grant or award of IPSC on Dec 9, 2025. It became public on Apr 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Murphy Martin Patrickcik:0002127581
Issuer
Century Therapeutics, Inc.cik:0001850119
Revision history · 0
No field has changed since this record was first ingested.
